Trial NCT04723394
Publication TACKLE - Montgomery H, Lancet Respir Med (2022) (published paper)
Primary outcome on the report: A composite of either severe COVID-19 or death from any cause through to day 29; adverse events, serious adverse events, and adverse events of special interest throughout the study.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.